MarketPulse

SLE

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Zenas Biopharma, Inc.

Zenas BioPharma Extends Runway to 2029 Amid Expanded Pipeline Push

Zenas BioPharma reported $718.5M cash position and Q2 2029 runway while advancing multiple clinical programs including obexelimab toward FDA/EMA submissions.
WXXWYZBIOEMA approvalclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

SLE Drug Race Heats Up: 120+ Pharma Giants Develop 140+ Pipeline Therapies

Over 120 pharmaceutical companies are developing 140+ drugs for systemic lupus erythematosus, with major players like Roche and Novartis advancing promising new treatment mechanisms.
JNJABBVNVSRHHBYAZN+3FDA approvalclinical trials